Accelerated Atherosclerosis

(redirected from Premature Atherosclerosis)

Accelerated Atherosclerosis

Atherosclerosis which occurs in a person with certain risk factors—e.g., SLE, diabetes, smoking, hypertension, hypercholesterolaemia, family history of early heart disease—at an earlier age than would occur in another person without those risk factors.
References in periodicals archive ?
Doctors say due to rheumatoid arthritis, a state of ongoing inflammation in the body leads to premature atherosclerosis, hypertension, coronary artery disease, cerebrovasular accidents and reduces lifespan by 10 years.
Apart from the classical cardiac manifestation of RA including pericarditis, cardiomyopathy, myocarditis, cardiac amyloidosis, coronary vasculitis, arrhythmia and valve diseases, congestive heart failure, ischaemic heart disease and premature atherosclerosis are known to occur more frequently and are associated with an increased mortality compared with the general population.
An isolated reduced high-density lipoprotein cholesterol (HDL-C) is reported to be as a risk factor for premature atherosclerosis [7].
Unrecoverable risk factors include older age, male gender, and family history of premature atherosclerosis.
Formation of plaques in the heart may lead to premature atherosclerosis and coronary artery disease (CAD), while formation of plaques in vessels of the brains can lead to cerebrovascular disease.
Vascular dysfunction caused by endothelial dysfunction is an early abnormality in the MetS that may contribute to premature atherosclerosis (2).
Research has shown that visceral fat is a source of inflammation that contributes to premature atherosclerosis and risk of acute coronary syndrome.
Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis.
1) If it is left untreated, markedly premature atherosclerosis is the usual outcome.
Premature atherosclerosis in patients with systemic lupus erythematosus (SLE) may develop as a result of a combination of disease- and therapy-related factors, classic coronary artery disease risk factors, and genetic factors.
Irbesartan, an angiotensin type 1 receptor inhibitor, regulates markers of inflammation in patients with premature atherosclerosis.